# Pharmacokinetics, efficacy and safety of daclatasvir plus asunaprevir in dialysis patients with chronic hepatitis <scp>C</scp>: pilot study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/pharmacokinetics-efficacy-and-safety-of-daclatasvir-plus-asunaprevir-in-dialysis/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Y. Kawakami,Michio Imamura,Hiroki Ikeda,Marcelino T. Suzuki,Keiko Arataki,Misaki Moriishi,Naoki Mori,Keiko Kokoroishi,Yoshio Katamura,T. Ezaki,Toshinori Ueno,Kentaro Ide,Tsutomu Masaki,Hideki Ohdan,Kazuaki Chayama |
| Citations | 39 |
| DOI | 10.1111/jvh.12553 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2465804291 |
| PMID | 27346670 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Toshinori Ueno](https://scholariq.org/researchers/toshinori-ueno/)

## Paper primary topic

- [Hepatitis C virus research](https://scholariq.org/topics/hepatitis-c-virus-research/)

## Paper topics

- [Hepatitis C virus research](https://scholariq.org/topics/hepatitis-c-virus-research/)
- [HIV/AIDS drug development and treatment](https://scholariq.org/topics/hiv-aids-drug-development-and-treatment/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.